Influenza vaccine and the risk of relapse of Guillain-Barré syndrome.
Wijdicks
E F
EF
Mayo Clinic and Foundation, Department of Neurology, Rochester, MN 55905, USA. wijde@mayo.edu
Fletcher
D D
DD
Lawn
N D
ND
D020275:Guillain-Barre Syndrome / Q000453:epidemiology*; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012307:Risk Factors
D007252:Influenza Vaccines